First-line drug selection versus sequential treatment in advanced pancreatic cancer: Does it really matter? Multi-institutional Canadian perspective.

I. Barrera,Neha Papneja,Jill Ranger,Abhishek Papneja,Petr Novotny,Shahid Ahmed,Gerald Batist,Petr Kavan

First-line drug selection versus sequential treatment in advanced pancreatic cancer: Does it really matter? Multi-institutional Canadian perspective.

2020

I. Barrera
Neha Papneja
Jill Ranger
Abhishek Papneja
Petr Novotny
Shahid Ahmed
Gerald Batist
Petr Kavan

673Background: Folfirinox (FFX) and Gemcitabine with nab-Paclitaxel (GN) are both proven to be superior to Gemcitabine (G) in the first line treatment (1LTx) for advanced pancreatic cancer (APC). Y...

Keywords:

Internal medicine
Pancreatic cancer
first line
Sequential treatment
Oncology
Medicine
Drug
Physical therapy
FOLFIRINOX
Gemcitabine
Pathology
first line treatment

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations